TS

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Tenaris (TS) have what it takes?

Toronto, Ontario – TheNewswire - July 15, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), today announced the initiation of its Phase IIb clinical trial site at  Hannover Medical School, Hanover (“MHH”), Germany, for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults.   The trial, which previously received regulatory clearance from Germany's Federal Institute for Drugs and Medical Devices and MHH's ethics committee , is now advancing towards the next stage at Hannover Medical School, one of the key clinical sites of the study. SCI-110 combines dronabinol with the endocannabinoid-like palmitoylethanolamide in an innovative one dosage form designed to reduce tics and comorbid symptoms in adults with TS while minimizing side effects.

PARAMARIBO, Suriname, June 30, 2026 (GLOBE NEWSWIRE) -- Tenaris announced today that operations have started at its new service center in Suriname, built to support the GranMorgu project, the country's first major offshore development, operated by TotalEnergies, with APA Corporation and Staatsolie Maatschappij Suriname N.V. as partners. Located in Paramaribo, the center will provide integrated services for offshore operations, reinforcing Tenaris's commitment to the development of Suriname's energy sector.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Tenaris (TS) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Tenaris (TS) have what it takes?

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free Cash Flow, Net cash / debt and Operating working capital days. See exhibit I for more details on these alternative performance measures.

Get a deeper insight into the potential performance of Tenaris (TS) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Structural underinvestment left global oil supply one shock away from a crisis, and the Hormuz blockage is that shock. With no quick fix to supply constraints, high and volatile oil prices aren't going away, and neither is the incentive to invest in oil and gas.

Case filed by InterPro Pipe + Steel, Canada's Only 100% Domestic Steel Producer for Tubular Steel Needed by the Energy Sector